|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 2, 369-375, October 1961
Copyright © 1961 by Lipid Research, Inc.
Department of Biochemistry, Research Division, Abbott Laboratories, North Chicago, Illinois
An experimental drug, diphenylmethylacetyl-N-methylpiperazine (A-11850), was found to stimulate the incorporation of acetate-1-C14, but not that of mevalonate-2-C14, into the fatty acid and nonsaponifiable fractions of rat liver slices. In addition, the drug increased about equally the oxidation of both glucose-1-C14 and glucose-6-C14 to C14O2. The incubation of liver slices in a buffer containing a high level of potassium ion stimulated lipogenesis in the same manner as the drug; with potassium ion, however, the oxidation of glucose-1-C14 was increased to a much greater extent than that of glucose-6-C14. Potassium ion also stimulated glucose oxidation in liver homogenates, whereas A-11850 did not.
Submitted on January 20, 1961
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |